Hongkun Qin

机构：China Pharmaceutical University

发表论文 7 篇 · 总被引 88 次 · h-index 5

代表论文

• AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma (2022 · Oncogene · 被引 34)
• Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP3R1/AKT/β-catenin pathway (2020 · Life Sciences · 被引 17)
• miR-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma (2021 · Frontiers in Oncology · 被引 15)
• Glioma–astrocyte connexin43 confers temozolomide resistance through activation of the E2F1/ERCC1 axis (2024 · Neuro-Oncology · 被引 12)
• Dodder-transmitted mobile systemic signals activate a salt-stress response characterized by a transcriptome change in Citrus sinensis (2022 · Frontiers in Plant Science · 被引 8)
• Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a (2022 · Journal of Visualized Experiments · 被引 2)